Galapagos NV To Present GLPG0634 And GLPG0974 At International Conference On IBD

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MECHELEN, Belgium, Feb. 21, 2014 (GLOBE NEWSWIRE) -- Galapagos NV (Euronext: GLPG) announced today that the Company will present posters on GLPG0634 and GLPG0974 at the European Crohn’s and Colitis Organisation annual meeting, taking place from 20 to 22 February 2014 in Copenhagen, Denmark. The full abstracts can be accessed through the ECCO website .

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC